Sacubitril/valsartan in patients with heart failure with reduced ejection fraction with end‐stage of renal disease

AIMS: Sacubitril/valsartan (SV) reduced heart failure hospitalization and cardiovascular mortality compared with enalapril in the Prospective Comparison of ARNI with ACE‐I to Determine Impact on Global Mortality and Morbidity in Heart Failure trial. However, this trial excluded patients with end sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seonhwa, Oh, Jaewon, Kim, Hyoeun, Ha, Jaehyung, Chun, Kyeong‐hyeon, Lee, Chan Joo, Park, Sungha, Lee, Sang‐Hak, Kang, Seok‐Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261577/
https://www.ncbi.nlm.nih.gov/pubmed/32153122
http://dx.doi.org/10.1002/ehf2.12659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261577/
https://www.ncbi.nlm.nih.gov/pubmed/32153122
http://dx.doi.org/10.1002/ehf2.12659

Ejemplares similares